Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis

Systematic Review: Comparative Effectiveness of Core-Needle and Open Surgical Biopsy to Diagnose Breast Lesions

(2013) Wendy Bruening   ANNALS OF INTERNAL MEDICINE

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour

(2011) Veronique Lorgis et al.   BREAST

Breast Hormonal Receptors Test Should Be Repeated on Excisional Biopsy After Negative Core Needle Biopsy

(2011) Thaer Khoury et al.   Breast Journal

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

(2011) José Baselga et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

(2011) José Baselga et al.   NEW ENGLAND JOURNAL OF MEDICINE

Accurately Assessing HER-2/neu Status in Needle Core Biopsies of Breast Cancer Patients in the Era of Neoadjuvant Therapy: Emerging Questions and Considerations Addressed

(2010) Timothy DʼAlfonso et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

(2010) Hitoshi Tsuda et al.   BMC CANCER

Breast Cancer Hormone Receptor Assay Results of Core Needle Biopsy and Modified Radical Mastectomy Specimens From the Same Patients

(2010) Gemma B. Uy et al.   Clinical Breast Cancer

Reliability of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry in Breast Core Needle Biopsies

(2010) Annette Lebeau et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)

(2009) M. Arnedos et al.   ANNALS OF ONCOLOGY

Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer

(2009) Sophia K Apple et al.   MODERN PATHOLOGY

Comparison of molecular markers expression in vacuum-assisted biopsies and surgical specimens of human breast carcinomas

(2009) Flora Zagouri et al.   PATHOLOGY RESEARCH AND PRACTICE

The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer

(2008) So Yeon Park et al.   AMERICAN JOURNAL OF SURGERY

Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression

(2008) S Abdsaleh et al.   HISTOPATHOLOGY

Diagnostic Accuracy and Prognostic Value of Core Biopsy in the Management of Breast Cancer: A Series of 542 Patients

(2008) Christiane Richter-Ehrenstein et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer

(2007) Anna Sutela et al.   ACTA ONCOLOGICA